A new gonorrhoea drug was developed by a non-profit foundation
Antibiotics are not commercially attractive to pharmaceutical firms
GONORRHoEA IS an old affliction. The book of Leviticus mentions a contagious condition involving the continuous emission of semen and a painful erection. Only 2,500 years later, in the mid-20th century, did the discovery of antibiotics bring relief.
But not, perhaps, for long. Decades of exposure to antibiotics have led N. gonorrhoeae, the bacterium that causes the disease, to develop resistance. With few new antibiotics coming onto the market, the bug is once again gaining the upper hand. Failures of treatment are being reported in many countries. It is now designated a “priority” pathogen by the World Health Organisation.
This article appeared in the Science & technology section of the print edition under the headline "Be rich in good deeds"
More from Science and technology
Archaeologists identify the birthplace of the mysterious Yamnaya
The ancient culture, which transformed Europe, was also less murderous than once thought
Producing fake information is getting easier
But that’s not the whole story, when it comes to AI
Disinformation is on the rise. How does it work?
Understanding it will lead to better ways to fight it